[Exploring the research on the molecular mechanisms of autoimmune liver diseases] [0.03%]
[探究自身免疫性肝病分子机制的研究]
Y Q Liu,X W Jiang,Y Li et al.
Y Q Liu et al.
Autoimmune liver diseases include subtypes such as autoimmune hepatitis and primary biliary cholangitis, which are caused by abnormal immune system attacks on hepatocytes or bile ducts. This article reviews their molecular mechanisms from t...
[The value of the nutritional assessment index or score in prognostic evaluation for patients with liver cancer] [0.03%]
营养评估指数或评分在肝癌预后评价中的价值
J C Shen,J Kang,Y Lei et al.
J C Shen et al.
Liver cancer is a common malignant tumor and a leading cause of mortality worldwide, which currently lacks standardized prognostic assessment criteria. Nutritional factors are crucial for patients with liver cancer prognosis, and there are ...
[Novel advances following the integration of Baveno VII consensus definitions for the non-invasive testing of portal hypertension] [0.03%]
Baveno Ⅶ共识算法用于非侵入性诊断门脉高压相关并发症的新进展
J L Chen,C Q Yang
J L Chen
Portal hypertension (PH) is a common and severe complication, which significantly affects patients with liver cirrhosis' quality of life and prognosis. In recent years, the assessment and management of PH have gradually gained attention, es...
[Exploration and application of nanotechnology in precision transarterial chemoembolization for hepatocellular carcinoma] [0.03%]
纳米技术在肝细胞癌精准经导管动脉化疗栓塞治疗中应用的探索与思考
J Q Kong,R Li,R N Zuo et al.
J Q Kong et al.
Transarterial chemoembolization (TACE) is a first-line therapy for intermediate-to-advanced- stage hepatocellular carcinoma, but its clinical efficacy is often limited by incomplete embolization, systemic toxicity of chemotherapeutic drugs,...
W K Gao,S Q Yan,J K Che et al.
W K Gao et al.
Drug-induced liver injury (DILI) is a condition that is induced by the hepatocellular toxicity of drugs or their metabolites or by hypersensitivity reactions of the liver to drugs and their metabolites. Clinical heterogeneity is high, with ...
[Research advances on hepatic encephalopathy following transjugular intrahepatic portosystemic shunt] [0.03%]
经颈静脉肝内门体分流术后肝性脑病的研究进展
J J Ye,Y L Pan,J Wang et al.
J J Ye et al.
Transjugular intrahepatic portosystemic shunt (TIPS) is an important therapeutic method for complications of portal hypertension in cirrhosis, but the high incidence rate of postoperative hepatic encephalopathy seriously affects patient pro...
[Research progress on the multidimensional regulation of gut microbiota on metabolism, immunity, and inflammatory response in metabolic associated fatty liver disease] [0.03%]
[肠道菌群代谢、免疫及炎症反应的多维度调节在代谢相关性脂肪肝病的研究进展]
S T Wu,X L Lu
S T Wu
Metabolic associated fatty liver disease (MAFLD) is the main cause of chronic liver disease and hepatic dysfunction, with its incidence rate increasing year by year in China. The gut microbiota and its metabolites promote the occurrence and...
[Clinical features and pathological scoring analysis of hepatic amyloidosis] [0.03%]
肝淀粉样变的临床特征及病理评分分析
Y X Gong,Z X Du,Y Yang et al.
Y X Gong et al.
Objective: To explore the relationship between clinical manifestations and pathological features so as to provide a theoretical basis for the assessment of the condition in patients with hepatic amyloidosis. Methods: Twelve patients diagnos...
[Impact of anti-gp210 and anti-centromere antibody dual positivity on clinical prognosis in patients with primary biliary cholangitis: risk analysis and establishment of response criteria] [0.03%]
抗gp210和抗着丝点双重抗体阳性对原发性胆汁性胆管炎临床预后的影响：风险分析与反应标准的建立
J Luo,D W Ding,G Y Guo et al.
J Luo et al.
Objective: To explore the impact and establish biochemical response criteria for optimized risk stratification for anti-glycoprotein (gp) 210 and anti-centromeric antibodies (ACA) dual positivity on the prognosis of patients with primary bi...
[Construction of a predictive model for recompensation in patients with decompensated viral hepatitis-induced cirrhosis] [0.03%]
失代偿期病毒性肝炎肝硬化再补偿预测模型的构建
D Q Xu,H Mu,C F Sa et al.
D Q Xu et al.
Objective: To explore the influencing factors and construct a predictive model for recompensation in patients with decompensated viral hepatitis-induced cirrhosis. Methods: Data were retrospectively collected from 734 cases diagnosed with d...